Literature DB >> 8814723

Quantifying brain tumor blood flow by the microsphere model with N-isopropyl-p-[123I]iodoamphetamine super-early SPECT.

H Namba1, M Yanagisawa, N Yui, T Togawa, F Kinoshita, Y Iwadate, K Sueyoshi.   

Abstract

Regional cerebral blood flow was quantitatively measured in 6 patients with brain tumor by the microsphere model with N-isopropyl-p-[123I]iodoamphetamine (IMP) "super-early" single photon emission computed tomography (SPECT) images obtained 4-6 min after IMP injection with a three-head rotating gamma camera. The ratio of radioactivities (counts/pixel/min) in the "early" SPECT images (taken 25-55 min after IMP injection) to the "super-early" images of the brain tumors was 1.47 +/- 0.13 (mean +/- SD, n = 6), which was significantly lower than the ratio in the normal cerebral cortices (1.93 +/- 0.25) (p < 0.01). This indicates faster clearance of IMP from the tumor tissue than that from the normal brain tissue. Blood flow values for the brain tumors obtained by the microsphere model based on the "super-early" SPECT images were 39.3 +/- 12.4 ml/100 g/ min, which was similar to the blood flow values for normal gray matter and in agreement with previous studies with positron emission tomography.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8814723     DOI: 10.1007/bf03165072

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  11 in total

1.  Decreased accumulation of isopropyl-lodoamphetamine (I-123) in brain tumors.

Authors:  N D LaFrance; H N Wagner; P Whitehouse; E Corley; T Duelfer
Journal:  J Nucl Med       Date:  1981-12       Impact factor: 10.057

2.  Early and delayed single photon emission CT in various cerebral diseases using N-isopropyl-p-(123I)iodoamphetamine.

Authors:  T Ueda; K Kinoshita; K Watanabe; H Hoshi; S Jinnouchi
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

3.  Dynamic SPECT with iodine-123 IMP in meningiomas.

Authors:  S Nakano; K Kinoshita; S Jinnouchi; H Hoshi; K Watanabe
Journal:  J Nucl Med       Date:  1988-10       Impact factor: 10.057

4.  Unusual uptake and retention of I-123 IMP in brain tumors.

Authors:  S Nakano; K Kinoshita; S Jinnouchi; H Hoshi; K Watanabe
Journal:  Clin Nucl Med       Date:  1988-10       Impact factor: 7.794

5.  [Blood flow measurement of brain tumor by 123I-IMP using 3-heads rotating gamma camera SPECT].

Authors:  M Ishihara; N Yui; T Togawa; S Minoshima; Y Uchida; H Namba; F Kinoshita; M Koakutsu; N Arimizu
Journal:  Kaku Igaku       Date:  1991-12

6.  Functional mapping of flow and back-diffusion rate of N-isopropyl-p-iodoamphetamine in human brain.

Authors:  Y Yonekura; S Nishizawa; T Mukai; Y Iwasaki; H Fukuyama; M Ishikawa; N Tamaki; J Konishil
Journal:  J Nucl Med       Date:  1993-05       Impact factor: 10.057

7.  In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas.

Authors:  C G Rhodes; R J Wise; J M Gibbs; R S Frackowiak; J Hatazawa; A J Palmer; D G Thomas; T Jones
Journal:  Ann Neurol       Date:  1983-12       Impact factor: 10.422

8.  A new noninvasive quantitative assessment of cerebral blood flow using N-isopropyl-(iodine 123)p-iodoamphetamine.

Authors:  H Matsuda; S Higashi; S Tsuji; H Seki; H Sumiya; H Fujii; H Oba; H Terada; K Imai; N Tonami
Journal:  Am J Physiol Imaging       Date:  1987

9.  Theoretical and experimental assessment of the kinetic properties of N-isopropyl-p-[123I]iodoamphetamine in the human brain.

Authors:  K Mori; K Nakajima; M Maeda
Journal:  Neurol Med Chir (Tokyo)       Date:  1993-12       Impact factor: 1.742

10.  Quantifying local cerebral blood flow by N-isopropyl-p-[123I]iodoamphetamine (IMP) tomography.

Authors:  D E Kuhl; J R Barrio; S C Huang; C Selin; R F Ackermann; J L Lear; J L Wu; T H Lin; M E Phelps
Journal:  J Nucl Med       Date:  1982-03       Impact factor: 10.057

View more
  1 in total

Review 1.  Imaging hemodynamics.

Authors:  Dominique Jennings; Natarajan Raghunand; Robert J Gillies
Journal:  Cancer Metastasis Rev       Date:  2008-12       Impact factor: 9.264

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.